Nephrotoxic Chemotherapy Agents: Old and New
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Advances in Chronic Kidney Disease
- Vol. 27 (1) , 38-49
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Incidence and risk of hypomagnesemia in advanced cancer patients treated with cetuximab: A meta-analysisOncology Letters, 2013
- Onco-NephrologyClinical Journal of the American Society of Nephrology, 2012
- Inhibition of MTOR Disrupts Autophagic Flux in PodocytesJournal of the American Society of Nephrology, 2012
- Mechanisms of Cisplatin NephrotoxicityToxins, 2010
- Treatment with IFN-α, -β, or -γ Is Associated with Collapsing Focal Segmental GlomerulosclerosisClinical Journal of the American Society of Nephrology, 2010
- FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell CarcinomaThe Oncologist, 2010
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trialThe Lancet, 2008
- VEGF Inhibition and Renal Thrombotic MicroangiopathyNew England Journal of Medicine, 2008
- Interferon α sensitisation induced fatal renal insufficiency in a patient with chronic myeloid leukaemia: case report and review of literature: Figure 1Journal of Clinical Pathology, 2006
- Ifosfamide/MesnaDrugs, 1991